Medical News

RSS

New infectious diseases blueprint for action

New vaccines are available to make significant gains against cervical cancer deaths and debilitating pain from shingles, but infectious diseases experts warn that their full potential will not be realized without changes in the way vaccines for adults and adolescents are promoted, financed, and delivered in the United States.

19 Jun 2007

Alcohol may protect against rheumatoid arthritis

New data presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain, suggests that alcohol may protect against rheumatoid arthritis, with three units a week exhibiting protective effects and ten units a week being more protective still.

19 Jun 2007

Elevator-related injuries in children

In the first large-scale epidemiological study evaluating elevator-related injuries in children throughout the United States, researchers from the Indiana University School of Medicine and a colleague from Ohio State University report on the large number of these preventable injuries.

19 Jun 2007

Many of the areas of the human genome previously thought to be deserts are in fact teeming with life

Most known human genes in the genome map are still incompletely annotated, says Professor Alexandre Reymond, from the Centre for Integrative Genomics, University of Lausanne, Switzerland and the Department of Genetic Medicine, University of Geneva, Geneva, Switzerland.

19 Jun 2007

How 'memory' T cells protect the body from viral diseases

A scientific discovery by Fox Chase Cancer Center researchers helps explain how 'memory' T cells protect the body from viral diseases.

19 Jun 2007

Women infected with bacteria known to cause periodontal disease more likely to have more severe oral bone loss

A study conducted in a large sample of postmenopausal women by University at Buffalo epidemiologists has provided new information on the prevalence of certain gum-disease-causing oral bacteria in this population and the association of the bacteria with oral bone loss.

19 Jun 2007

Genzyme announces results of clinical trials of Renvela and Renagel

Genzyme Corp. has announced the results of two new studies comparing a powder form of Renvela (sevelamer carbonate) to Renagel tablets (sevelamer hydrochloride), including one trial in which patients received the powder form three times per day, and one in which it was administered once per day.

19 Jun 2007

Otosclerosis gene identified

A gene responsible for the single most common cause of hearing loss among white adults, otosclerosis, has been identified for the first time, a scientist told the annual conference of the European Society of Human Genetics in Nice, France.

19 Jun 2007

Results of Tocilizumab study

Nearly half (43.9%) of rheumatoid arthritis (RA) patients receiving tocilizumab 8mg/kg, in addition to ongoing methotrexate therapy experienced a 50% (ACR50) improvement in symptoms at 24 weeks and more than one fifth achieved a 70% symptom improvement, according to results of a study presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.

19 Jun 2007

Common DNA variations underlie susceptibility to fever after smallpox vaccination

Their finding is the first to link individual differences written into the genetic code with a vaccine-related complication, albeit a mild one.

19 Jun 2007

True nature of heterochromatin revealed

Not so long ago, the difficult-to-sequence, highly repetitive, gene-poor DNA found in regions of chromosomes known as heterochromatin was called "junk." Like dark matter in the universe, the true nature of heterochromatin was unknown.

19 Jun 2007

Analysis of steroids as a treatment for sudden hearing loss

Although steroids are the most widely used treatment for sudden hearing loss, little scientific evidence supports their use or that of any other therapies for this condition, according to a systematic review and meta-analysis both published in the June issue of Archives of Otolaryngology, Head & Neck Surgery.

19 Jun 2007

Pepsin associated with acute rejection of a lung transplant

Researchers in the United Kingdom have demonstrated that high levels of pepsin, a digestive enzyme that is a marker for gastric aspiration, are associated with acute rejection of a lung transplant.

19 Jun 2007

Do common treatments for ADHD increase risk of drug abuse?

Parents, doctors, and others have wondered whether common treatments for attention-deficit hyperactivity disorder (ADHD) inadvertently predispose adolescents to future drug abuse.

19 Jun 2007

Alli hits the stores

The first non-prescription diet drug ever to be approved by the FDA hit the shops this week and optimistic dieters are dashing out to buy it.

19 Jun 2007

Doctoral research without borders

The enabling of structured doctoral research within a collaborative scientific network has been the declared objective of the Research Training Group Programme, offered by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), since its inception in 1990.

19 Jun 2007

Columbia dentists target chronic oral health problems in sub-Saharan Africa

A new initiative from Columbia University Medical Center will be the first to target chronic oral health problems in sub-Saharan Africa, where the vast majority of chronic diseases are left undetected and untreated.

19 Jun 2007

Scientists discover proteins in blood that accurately identify colon cancer and precancerous polyps

Initial studies of the proteins, CCSA-3 and CCSA-4, suggest they could be used to develop a blood test to identify at-risk individuals.

19 Jun 2007

Embryos that are selected out as abnormal can undergo chromosomal modifications

Ms Tsvia Frumkin, from the Racine IVF unit, LIS Maternity Hospital, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel, will tell the conference that her team's findings meant that the results of preimplantation genetic screening (PGS) for chromosomal abnormalities were not always reliable and should be interpreted with caution.

19 Jun 2007

Cancer stem cells similar to normal stem cells thwart anti-cancer agents

Current cancer therapies often succeed at initially eliminating the bulk of the disease, including all rapidly proliferating cells, but are eventually thwarted because they cannot eliminate a small reservoir of multiple-drug-resistant tumor cells, called cancer stem cells, which ultimately become the source of disease recurrence and eventual metastasis.

19 Jun 2007